CVAR - ETF AI Analysis

Top Page

Cultivar ETF (CVAR)

Rating:56Neutral

Price Target:―

The Cultivar ETF (CVAR) has a balanced overall rating, reflecting both strengths and challenges within its holdings. Strong contributors like Newmont Mining (NEM), with its robust financial performance and strategic initiatives, and Hershey (HSY), supported by strong financial health and market positioning, positively impact the fund's rating. However, weaker holdings such as Alexandria Real Estate (ARE), which faces significant financial challenges and declining profitability, weigh on the overall score. A key risk factor for the ETF is its exposure to holdings with valuation concerns and financial instability, which could affect its future performance.

Positive Factors

Strong Year-to-Date Performance

The ETF has delivered solid gains so far this year, indicating strong overall momentum.

Broad Sector Diversification

The fund is spread across 11 sectors, reducing the risk of being overly reliant on any single industry.

Exposure to High-Performing Holdings

Several top holdings, such as Barrick Mining and Newmont Mining, have shown strong year-to-date performance, contributing positively to the fund.

Negative Factors

High Expense Ratio

The ETF charges a relatively high fee compared to many other funds, which can eat into investor returns over time.

Underperforming Top Holdings

Some major positions, like Marketaxess Holdings and Core Laboratories, have struggled this year, potentially dragging down overall performance.

Heavy U.S. Exposure

With nearly 87% of assets in U.S. companies, the fund lacks geographic diversification and is vulnerable to domestic market risks.

CVAR vs. SPDR S&P 500 ETF (SPY)

AUM38.90M

RegionNorth America

Expense Ratio0.87%

Beta0.58

IssuerCultivar

Inception DateDec 21, 2021

Dividend YieldN/A

Asset ClassEquity

Index TrackedNo Underlying Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume593

30 Day Avg. Volume1,100

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

31.40

Price Target Upside― Downside

Rating ConsensusHold

Number of Analyst Covering87

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

CVAR Summary

The Cultivar ETF (CVAR) is a fund that focuses on value investing, targeting companies across the entire market that are considered undervalued but have strong fundamentals. It includes a mix of large, mid, and small-cap stocks, offering exposure to sectors like healthcare, technology, and consumer defensive. Well-known companies in the fund include Intel and Southwest Airlines. Investors might consider CVAR for diversification and the potential for steady growth during market recoveries. However, new investors should be aware that value investing can take time to show results and the ETF’s performance may fluctuate with overall market conditions.

How much will it cost me?The Cultivar ETF (CVAR) has an expense ratio of 0.87%, which means you’ll pay $8.70 per year for every $1,000 invested. This expense ratio is higher than average because the fund is actively managed, focusing on identifying undervalued companies with strong fundamentals rather than simply tracking an index.

What would affect this ETF?The Cultivar ETF (CVAR) could benefit from a recovery in the U.S. economy, as value investing strategies often perform well during periods of market stability and growth. Positive trends in sectors like Health Care and Technology, which make up significant portions of the ETF, could also drive returns. However, rising interest rates or economic uncertainty might negatively impact some of its top holdings, such as real estate and energy companies, and broader market volatility could challenge its value-focused approach.

CVAR Top 10 Holdings

The Cultivar ETF (CVAR) leans heavily on value stocks across diverse sectors, with a notable focus on health care and consumer defensive names. Healthcare Services is a rising star, benefiting from strong financial performance and low debt, while Albemarle and Newmont Mining are also gaining momentum, driven by bullish technical trends and demand in energy and mining markets. However, Alexandria Equities is dragging the fund with declining occupancy and profitability concerns. With its U.S.-centric portfolio, CVAR offers a balanced but sectorally diverse approach to value investing, though some holdings face headwinds.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
MKTX	Marketaxess Holdings	4.00%	$1.55M	$6.42B	-20.68%	68 Neutral
CLB	Core Laboratories	3.54%	$1.38M	$904.73M	1.67%	72 Outperform
LUV	Southwest Airlines	3.00%	$1.16M	$22.00B	32.31%	66 Neutral
HCSG	Healthcare Services	2.45%	$952.22K	$1.32B	60.05%	72 Outperform
ALB	Albemarle	2.30%	$893.25K	$20.90B	86.60%	58 Neutral
ARE	Alexandria Equities	2.24%	$870.39K	$9.70B	-43.91%	47 Neutral
B	Barrick Mining	2.19%	$850.35K	$84.24B	217.14%	―
NEM	Newmont Mining	2.07%	$805.10K	$124.57B	174.07%	81 Outperform
NWN	Northwest Gas	2.04%	$791.32K	$1.93B	18.09%	73 Outperform
HSY	The Hershey Company	1.73%	$673.42K	$40.38B	31.22%	76 Outperform

CVAR Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

28.10

Positive

100DMA

27.85

Positive

200DMA

26.72

Positive

Market Momentum

MACD

0.39

Negative

RSI

75.85

Negative

STOCH

98.87

Negative

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For CVAR, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 28.86, equal to the 50-day MA of 28.10, and equal to the 200-day MA of 26.72, indicating a bullish trend. The MACD of 0.39 indicates Negative momentum. The RSI at 75.85 is Negative, neither overbought nor oversold. The STOCH value of 98.87 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CVAR.

CVAR Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
CVAR	―	―	$38.90M	0.87%	―
BAMD	―	―	$95.00M	0.89%	―
TCV	―	―	$90.13M	0.85%	―
GMOV	―	―	$74.95M	0.50%	―
GVLE	―	―	$46.78M	0.45%	―
VUSV	―	―	$46.21M	0.30%	―

Performance Comparison

CVAR

Cultivar ETF

29.70

4.57

18.19%

BAMD

Brookstone Dividend Stock ETF

―

TCV

Towle Value ETF

―

GMOV

GMO US Value ETF

―

GVLE

Goldman Sachs Value Opportunities ETF

―

VUSV

Vanguard Wellington U.S. Value Active ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents